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Abstract
Inherited dentalmalformations constitute a clinically and genetically heterogeneous group of disorders. Here,we report on four
families, three of them consanguineous, with an identical phenotype, characterized by significant short stature with
brachyolmia and hypoplastic amelogenesis imperfecta (AI) with almost absent enamel. This phenotype was first described in
1996 by Verloes et al. as an autosomal recessive form of brachyolmia associated with AI. Whole-exome sequencing resulted in
the identification of recessive hypomorphic mutations including deletion, nonsense and splice mutations, in the LTBP3 gene,
which is involved in the TGF-beta signaling pathway. We further investigated gene expression duringmouse development and
tooth formation. Differentiated ameloblasts synthesizing enamel matrix proteins and odontoblasts expressed the gene. Study
of an available knockoutmousemodel showed that themutantmice displayed very thin to absent enamel in both incisors and
molars, hereby recapitulating the AI phenotype in the human disorder.
Introduction
Brachyolmia (from the greek ‘short trunk’) refers to a heterogeneous
group of skeletal dysplasias with as major clinical feature a dispro-
portionate short stature with short trunk. Radiographic abnormal-
ities are predominantly present in the axial skeleton and include
generalized platyspondyly (i.e. flattened vertebral bodies). Amelo-
genesis imperfecta (AI) is a defect in enamel formationandmineral-
ization (1). AI can be an isolated finding or occur in association with
otheranomalies (syndromicAI) (2). In1996,Verloes et al. (3)described
an autosomal recessive formof platyspondylywithAI [MIM601216].
Absence of enamel and oligodontia were themajor dental findings.
Bertola et al. (4) subsequently published two other families, one of
them with abnormal yellow coloration of primary and permanent
teeth, as well as retarded dental eruption compatible with a diag-
nosis of AI. Here we report on four families, three of them being
consanguineous, with an identical phenotype, characterized by
platyspondyly (brachyolmia) and AI. Affected individuals have
very thin or almost absent enamel. By using a combined strategy
of homozygosity mapping and whole-exome sequencing, recessive
mutations in the latentTGF-betabindingprotein 3 (LTBP3) genewere
identified. Analysis of ltbp3 expression during mouse development
and the studyof dental anomalies observed in the Ltbp3−/−knockout
mousemodel underscored the key role of the latent TGF-beta bind-
ing protein 3 in amelogenesis and skeletal development.
Results
Patients’ phenotype
The index family 1 presented with AI and short stature. The al-
most complete absence of enamel in bothprimaryandpermanent
dentitions (Fig. 1A and B) led to the diagnosis of hypoplastic AI,
thereby explaining the yellow, small and spaced appearance of
the teeth. The panoramic radiographs confirmed the absence of
enamel associatedwith large pulp chambers and taurodonticmo-
lars (Fig. 1C). Class III mandibular prognathism encountered in
family 1 was due to maxillary underdevelopment (Fig. 1D). Radio-
graphs of the skeleton revealed brachyolmia (Fig. 1E and F)
Subsequently, three additional families with a similar pheno-
typewere identified. Additional bone anomalies such as osteope-
nia and scoliosis were present in family 4. Missing teeth (family
4) and retarded teeth eruption (family 3) were also reported.
Enamel shows quantitative and qualitative defects
The enamel structure of a permanent tooth, the left upper second
premolar (25) extracted within the course of treatment of patient
IV-1 of family 1 was further analyzed by scanning electron mi-
croscopy (Fig. 1G and H). With this evaluation the enamel hypo-
plasia was confirmed and very thin or absent enamel was noted.
Dentin was normal. The initial aprismatic enamel layer was ab-
sent. A very thin shell of irregular prismatic enamel (PE), with a
reduced thickness thinner than 150 µm (instead of 300 µm com-
paratively at the same site on a control tooth), was deposited cov-
ering the dentin scaffold. In this layer, a Hunter-Schreger band
pattern, featuring the arrangement of enamel prisms, was pre-
sent. In these areas, no aprismatic outer layer was deposited.
However in some areas, amelogenesis continued and some ‘bub-
bling’ of non-prismatic enamel (NPE) occurred on top of this basal
first enamel layer. Waves of aprismatic and prismatic enamel al-
ternated. The outermost layer was always aprismatic in areas
where enamel formation continued.
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Mutations in LTBP3 underlie syndromic AI
with brachyolmia
Whole-exome sequencing was performed independently (in two
different labs) in families 1 and 2 and in families 3 and 4. Coverage
and variant calling data for families 1 and 2 are provided in
Supplementary Material, Table S1.
A single gene, LTBP3, was found to carry bi-allelic mutations
in all affected individuals from the four families (Fig. 2A and B).
In family 1, we identified a homozygous 14 bp deletion, c.[2071_
2084delTACCGGCTCAAAGC] (Table 1 and Fig. 2A). This mutation
lies within a zone of homozygosity that is shared between the
two affected individuals, but that is absent in the unaffected sib-
ling and parents (Supplementary Material, Fig. S1).
In family 2 we identified compound heterozygosity for a non-
sense and a splice donor sitemutation c.[421C>T];[1531+1G>T]; in
families 3 and 4 homozygosity for a single nucleotide deletion
was found (c.[2216_2217delG] in family 3 and c.[2356_2357delG]
Figure 1. Phenotypic data on family 1. (A) Intraoral viewof individual IV.1 (at age 5 years). All primary teeth are smaller andyellowish showing thin, almost absent, enamel. The
dentition is spaced. (B) Intraoral viewof individual IV.2 (at age 7years). Theeruptingpermanent incisors areyellowandsmall due toabsent enamel. Primary teethwere lost after
recurrent infections. (C) Panoramic radiograph of individual IV.2 (at age 9 years) showing erupted andnon-eruptedpermanent teethwith no enamel. No teetharemissing. Pulp
chambers appear large. Infection as a consequence of microbial contamination of pulp spaces is visible around the 36 (radiolucent area around the roots of the lower left first
permanentmolar filled star) in the absence of the protective enamel layer. The upward arrow points toward a second right lower permanentmolar not yet erupted presenting
with taurodontism and a large pulp chamber. (D–F) Radiographs taken from individual IV.2 (skull at age 9 years and spine at age 14 years). Skull radiograph reveals absent
pneumatization of sinuses and mandibular prognathism secondary to underdevelopment of the maxilla. The spine radiographs show platyspondyly with indentations of
both upper and lower vertebral endplates. (G) The enamel phenotype analyzed at the ultra-structural level through SEM revealed a thin PE layer directly starting at the
dentino-enamel junction (DEJ). In some areas enamel formation continued as an aprismatic layer (NPE). Dentin (DE) was normal. (H) Close up of the PE and NPE thin layer.









niversity user on 29 O
ctober 2020
Figure 2.Detected LTBP3mutations and corresponding protein domains. (A) Pedigrees and sequences analysis of families 1–4 (na: not available). Simplified pedigree of family 1 demonstrates consanguinity between the parents III.3 and
III.4. Electropherograms reveal a 14-bp homozygous deletion in the affected individuals IV.1 and IV.2. The parents III.3 and III.4 are heterozygous for the deletion. (B) The LTBP3 human gene is located on chr11q13.1, extends over 20 kb
and contains 28 exons (vertical gray hatches); the position of the start codon (ATG) and the stop codon (TGA) are indicated. Themutations detected in this study are bold and underlined, vertical lines indicate positions relative to exons
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in family 4). All mutations segregated with the disease phenotype
in each family and were confirmed by Sanger sequencing (Fig. 2).
In addition, they were absent in the Exome Variant Server (EVS)
and the Thousand Genomes Project Catalog. Interestingly a single
nucleotide insertion (c.2216_2217insG; p.Gly740Argfs*51) was
tabulated in EVS in the homozygous state in 7 out of more than
6098 individuals. However, coverage information was not available
for these individuals toverify if this is a falseor truepositivevariant.
The LTBP3mutations identified in our families are most likely
hypomorphic. The 14-bp deletion found in family 1 does not
seem to result in nonsense-mediated decay because it was
present in RNA extracted from a gingival biopsy of patient IV.1
(Supplementary Material, Fig. S2). The mutation most likely
gives rise to a truncated protein that lacks the terminal 612
amino acids,which encode essential functional domains (epider-
mal growth factor like-domain, TB domain, EGF-like calcium-
binding domain and insulin-like growth factor binding protein
domain) of the protein (Fig. 2C). The splice-site mutation in fam-
ily 2 is predicted to cause an in-frame skipping of exon 8. The
remainingmutations, onenonsensemutation and two single nu-
cleotide deletions, are expected to result in nonsense-mediated
decay through the creation of a premature stop codon.
Expression pattern of Ltbp3 in developing mouse
bone and tooth
To gain insight into Ltpb3 expression during bone and tooth devel-
opment in mice, we performed an in situ hybridization analysis,
using a digoxigenin-labeled antisense riboprobe generated from
the sameDNA template as previously used by the EURExpress con-
sortium (www.eurexpress.org). Mouse embryos were analyzed at
E14.5, E16.5 and E18.5. Ltbp3 transcripts were detected in several
developing tissues and organs. Expression was found in various
developing bones undergoing either endochondral or intramem-
branous ossification (e.g. the vertebrae: Fig. 3A; mandibular bone:
Fig. 3B; base of the skull bones: Fig. 3C). Expression was also de-
tected in the ventricular and subventricular zones of the develop-
ing brain vesicles (Fig. 3D), and in cells surrounding the lumen of
the neural tube (the spinal cord primordium: Fig. 3A). Discrete ex-
pression was observed in the developing inner ear (cochlea:
Fig. 3C). Ltbp3 transcripts were detected in the small and large
intestine, with most conspicuous expression at the base of the in-
testinal crypts (Fig. 3E). Weaker expression was seen in the differ-
entiating lung (Fig. 3F), whereas discrete expression was observed
in the heart outflow tract (not shown) and in the wall of the large
blood vessels such as the aorta and pulmonary artery (Fig. 3F).
Ltbp3 expression pattern was also investigated during tooth
development. In a large-scale gene expression study (www.
eurexpress.org), Ltbp3 transcripts were detected at E14.5 cap
stage of tooth development (6). This also has been documented
in a mouse tooth cap stage transcriptome analysis (6). Our ana-
lysis confirmed these data. In addition we investigatedmore pre-
cisely Ltbp3 expression at various stages of tooth development
(Fig. 3G, I and K lower incisor and H, J and L molar). Ltbp3 tran-
scripts were observed at E14.5 in cap stage teeth, at E16.5 in the
epithelial and mesenchymal compartments of the bell stage
teeth, especially in the most differentiated areas such as the
molar cusp tips and the rostral part of the incisors. At E18.5 label-
ing was observed in differentiating ameloblasts and odonto-
blasts. Transcripts were scattered at the apical secretory pole of
ameloblasts.
Ltbp3−/− mouse dental phenotype
We further explored the dental phenotype of Ltbp3−/− mice de-
scribed in (7–9) by X-ray micro-computed tomography (microCT)
and histological analysis to compare morphological phenotype
in mouse (10) and human. Ltbp3−/− mutant mice displayed en-
amel defects with very thin to absent enamel in both incisors
andmolars (Fig. 4). Hence, the Ltbp3−/−mousemodel clearly reca-
pitulates the AI phenotype observed in our patients. Mandibular
relative class III prognathism due to maxillary underdevelop-
ment, seen in patients IV.1 and IV.2 of family 1, was also present
in themutantmousemodel. Histological analysis of continuous-
ly growing incisor enamel organ revealed a cohesive, however at
defined localizations, non-palisadic ameloblasts layer facing a
thinner disorganized enamel matrix (Fig. 4M) confirming at the
cellular level the dysfunction of amelogenesis.
Discussion
Using a combined strategy of homozygositymapping andwhole-
exome sequencing in four unrelated families with the associ-
ation of brachyolmia and AI, we identified the LTBP3 (latent
TGF-beta binding protein 3) gene as the underlying causal gene
responsible for this rare autosomal recessive disorder [MIM
601 216]. Mutations in the LTBP3 gene have already been reported
in individuals with oligodontia (5), a dental developmental dis-
order defined by the absence of more than six permanent
teeth. The question therefore arises if mutations in LTPB3 can
cause different dental phenotypes and how we can explain the
presence of extra-dental manifestations such as brachyolmia in
our families.
One gene associated with different phenotypes?
A homozygous nonsensemutation in the LTBP3 genewas first re-
ported in a consanguineous Pakistani family with oligodontia (5).
Table 1. Mutations described in LTBP3 (NM_001130144.2)
Family Affected Ethnic origin #Exon Chromosomic
position (hg19)
cDNA change Protein change




2 Two siblings Caucasian French Exon 2 and 8 g.65321762 c.[421C>T(;)1531+1G>T] p.[Gln141*(;)?]
3 One boy Brazil Exon 15 g.65314283 c.[2216_2217delG]; [2216_2217delG] p.[Gly739Alafs*7];
[Gly739Alafs*7]
4 Three siblings Pakistan Exon 17 g.65311018 c.[2356_2357delG]; [2356_2357delG] p.[Val786Trpfs*82];
[Val786fs*82]
Mutation affecting splice are in italics.
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Based on the available data in the report, we believe that the oli-
godontia phenotype in this family was either related to early loss
of teeth due to enamel defects or caused by defective tooth devel-
opment leading to absent teeth. Close examination of the skull X-
ray of an affected patient in their published Figure 2 (5) clearly
shows absent enamel and short roots in the remaining teeth,
which suggests the diagnosis of an AI. Verloes et al. also men-
tioned oligodontia as a feature in his family with brachyolmia
and AI (3). Missing teeth were also found in our family 4. Oligo-
dontia may therefore be part of the clinical spectrum of this con-
dition. The affected individuals in the consanguineous Pakistani
family with oligodontia also presented with short stature. Vary-
ing degrees of scoliosis were apparently present but no other
skeletal anomalies were observed. The authors do not report flat-
tening of the vertebral bodies in their family and no lateral views
of the spine are shown in their article. Theyonly describe a higher
bonemineral density in the spine found by dual-energy X-ray ab-
sorptiometry. Although we cannot judge on the presence or ab-
sence of brachyolmia as cause of the short stature in the
affected individuals, we believe that this reported familywith oli-
godontia may be affected by the same disorder given the pres-
ence of a recessive mutation in the LTBP3 gene.
LTBP3 and TGF-beta acting as partners
The LTBP3 gene (NM_001130144.2, 11q13.1) spans 28 exons, has
20 372 base pairs and generates 22 different transcripts (only
twomajor transcriptswithCCDSnumber, eightwithout a protein
and two resulting in nonsense-mediated decay).
LTBP3 codes for a protein of the extracellular matrix that is
involved in regulation of TGF-beta secretion, trapping and
activation (11–13). LTBP3 (1139 amino acids, NCBI RefSeq: NP_
001157738.1; 1303 amino acids NM_001130144.2) is one of the
four members of the LTBP/fibrillin family and can form a large
complexwith latent TGF-beta 1, 2 and 3 (14). The LTBP protein do-
main structure consists of EGF-like calcium-binding conserved
domains, 4 TGF-beta-binding protein-like (TB) domains also
named eight cysteine repeats aswell as insulin-like growth factor
binding protein domains (Fig. 2). This domain structure is also
found in TGF-binding protein and fibrillins.
LTBP3 and AI
TGF-beta 1, 2 and 3 are growth factors involved in various bio-
logical functions such as cell growth and differentiation, extra-
cellular matrix secretion and remodeling. TGF-beta signaling is
essential for hair and tooth growth especially enamel formation.
Enamel is a complex structure secreted by ameloblasts present-
ing different successive stages during their life cycle. In mam-
mals it is possible to recognize an initial aprismatic enamel
layer at the dentin–enamel junction deposited by secreting ame-
loblasts without Tomes’ process, then the bulk of enamel with
rod and interrod compartments forms with secreting amelo-
blasts with Tomes’ process and finally the last-formed surface
aprismatic layer of enamel with the retraction of ameloblasts’
Tomes’ process (15). Ltbp3 expression pattern in differentiating
ameloblasts and odontoblasts is highly similar to that of TGF-
beta1 (16–18). Blockade of TGF-beta signaling results in a failure
of ameloblasts to produce an enamel layer in incisor teeth (11).
Overexpression of TGF-beta1 in teeth results in detachment of
ameloblasts and enamel defects (1,19). TGF-beta1 and TGF-beta
receptor 1 (TGFBR1) genes are strongly expressed in secreting
Figure 3. Analysis of mouse Ltbp3 transcripts distribution by in situ hybridization. Selected sections illustrating Ltbp3 expression features in the developing bone, central
nervous system and viscera are shown in the left-side panels (A–F), whereas right-side panels focus on incisor (G, I and K) and molar (H, J and L) tooth development.
Developmental stages and section planes are: E14.5 frontal (A, D, F, G and H), E16.5 sagittal (B, C, I and J); E18.5 sagittal (E, K and L) sections. Am, ameloblasts; Ao,
aorta; Co, cochlea; Di, diencephalon; DP, dental papilla; EL, epithelial loop; Gu, gubernaculum; IDE, inner dental epithelium; In, intestine (duodenum); LI, lower incisor;
Lu, lung; MC, Meckel’s cartilage; Md, mandible; NT, neural tube; Od, odontoblasts; ODE, outer dental epithelium; PA, pulmonary artery; PS, palatal shelves; SB, skull bone;
SR, stellate reticulum; Te, telencephalon; To, tongue; UM, upper molar; Ve, vertebrae. Scale bars: 40 µm (B and D–H); 50 µm (C, K and L); 80 µm (I and J); 150 µm (A).
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ameloblasts where they promote the expression of MMP20, an
enamel matrix protease (20). TGF-beta1 is also expressed later
in the maturation-stage ameloblasts and seems to play an im-
portant role in ameloblast apoptosis (21). In addition, TGF-β1 is
able to induce KLK4 (a protease degrading enamel proteins to in-
crease mineralization) expression (22,23). TGF-beta1 may also
control cell layer integrity for odontoblasts (24).
The enamel defects, observed in our families, at the ultra-
structural level (Fig. 1) with both the absence of the initial apris-
matic enamel layer and the abnormal secretion of non-prismatic
bulk enamel, strongly suggest a role of LTBP3 during the life cycle
of ameloblasts especially at the secretory stages with Tomes pro-
cess formation/modulation. The molecular mechanisms that
control the formation, function and retraction of Tomes’ process
Figure 4. MicroCT and histological analysis of Ltbp3−/− mice. The Quantum FX® microCT Pre-clinical In Vivo Imaging System is a low X-ray dose system devised for
longitudinal microCT in preclinical studies (Caliper Life Sciences, Inc., Hopkinton, MA, USA). Seven Ltbp3−/− mouse heads and seven WT littermates were analyzed.
(A–C) Normal macroscopic aspect of the mouse upper (A face, B side view) and lower incisors (C: side view). Note that the teeth are naturally colored yellow that
enamel is smooth and present only on the labial side. The lower incisors are twice as long as the upper. (D–F) Enamel defects encountered in Ltbp3−/− mouse. The
colored area is decreased and an irregular indented enamel surface is present. (G) Appearance of lower incisor from Ltbp3−/− mouse as observed by X-ray imaging.
Note irregular contour of thin enamel, a hypoplastic area, with limited or no enamel is seen on the labial side. (H–I) 3D reconstruction of microCT imaging
demonstrating the outer surface appearance and contact between continuously growing incisors in a WT mouse (H) or Ltbp3−/− mouse (I). The enamel surface is
reduced and the tooth surface irregular. (J–K) Normal (J: WT) and reduced (in size and density) enamel layer (K: Ltbp3−/− mouse), as observed when isolated from
dentin through its highest mineralization and therefore X-ray density degree. (L) Normal ameloblasts (Am) layer facing a highly organized decalcified enamel (E)
matrix. (M) In the Ltbp3−/− mouse, in certain area, the ameloblast layer became erratic, like blubbing and laid out a differently organized thinner enamel matrix.
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are not well understood. However clear molecular differences
exist between NPE and PE (25) and this may involve TGF-beta sig-
naling. Transgenic mice presenting with enamel defects such as
the amelotin (AMTN) overexpression model also exhibit enamel
defects in relationwith the disappearance of Tomes’ process (26).
We therefore formulate the hypothesis that TGF-beta signaling is
involved in themodulation of Tomes’ process and the deposition
of a decussating prisms enamel pattern. Interestingly, the Klk4
ablatedmice display rod/interod anomalies besides enamelmat-
uration defects (27).
LTBP3 and brachyolmia
LTBP3 is also involved in bone formation and remodeling. Inacti-
vation of LTBP3 reduces TGF-beta activation and therefore
diminishes associated cell proliferation and osteogenic differen-
tiation (28). TGF-beta is the most abundant growth factor in bone
playing amajor role in bone development and skeletogenesis, es-
pecially during endochondral ossification but also later in adult
bone homeostasis and remodeling (29). Deregulation of the
TGF-beta signaling pathway is likely to interfere with axial skel-
eton patterning (30).
Ltbp3 is expressed in cartilage primordia especially in devel-
oping vertebrae (7). Recently, genes such as TRPV4 (transient re-
ceptor potential cation channel, subfamily V, member 4 gene)
have been identified in autosomal dominant brachyolmia (31)
and PAPSS2 (3′-phosphoadenosine 5′-phosphosulfate synthase
2) in autosomal recessive brachyolmia (32). A direct relationship
may exist between the TGF-beta signaling pathway and the
TRPV4 and PAPSS2 genes. TRPV4 regulates cardiac fibroblast dif-
ferentiation to myofibroblasts by integrating signals from TGF-
beta1 and mechanical factors (33). Altered responsiveness to
TGF-beta results in reduced Papss2 expression and alterations
in the biomechanical properties of mouse articular cartilage (34).
The role of LTBP3 in bone development is also exemplified by
the Ltbp3−/− knockout mouse phenotype (7,8,35,36). These ani-
mals show growth retardation, obliteration of the skull synchon-
drosis within 2 weeks of birth, osteopetrosis of long bones and
vertebrae and osteoarthritis. Thoracic kyphosis (curvature of
the cervical and thoracic vertebrae) and distorted ribcage were
also observed in the mutant mice. The high bone mass was re-
lated to a defect in bone resorption with compromised osteoclast
function and decreased bone turnover (9). Platyspondyly how-
ever was not observed in the Ltbp3−/− knockout mice.
Awider phenotype
A previous report has described expression of LTBP3 in various
human tissues and cell lines, predominantly in heart, skeletal
muscle, prostate and ovaries, as well as testis and small intestine
(14). Ltbp3 was also found to be expressed in the rat brain, with a
partially overlapping expression with several other TGF-beta
family members (37). Basioccipital-basisphenoid synchondrosis
of P1 mouse expressed Ltbp3 in prehypertrophic chondrocytes.
Ltbp3 transcripts were also present in adult mouse tissues in
heart, brain, lung and kidney (7,8). We also report the transcrip-
tion of ltbp3 in brain vesicles, in cells surrounding the lumen of
the neural tube, in the developing inner ear, in the small and
large intestine, in the differentiating lung, in heart outflow tract
and in the wall of the large blood vessels (Fig. 3).
It is surprising that the mutations of LTBP3 in human seem to
affect only two organ systems, the skeleton and the teeth. It will
be very important to follow over time the cohort of patients to as-
sess the clinical relevance of this in situ hybridization data and to
record any additional occurring illness that may extent the
phenotype spectrum.
Ltbp3−/− knockout mouse model display an enamel
phenotype
Analyzing further the Ltbp3−/− knockout mouse with respect to
the craniofacial and orodental phenotypes was of importance
to convince that LTBP3 is indeed the causative gene behind bra-
chyolmia associated with AI.
As described in refs. (7–9) craniofacial malformations were
identified in Ltbp3−/− mice at postnatal day 12. By 3 months of
age mutant mice displayed a pronounced rounding of the cranial
vault, extensionof themandible beyond themaxilla andkyphosis.
The altered skull shape with occipital bossing was believed to be
caused by the premature ossification of the cranial base synchon-
droses. Shortened skull base and disproportionately short upper
jaw were evident. The external facial appearance was character-
ized by a rounded head and a shortened snout. Our analysis indi-
cated that almost all craniofacial structures were affected in the
Ltbp3-null mice. Alterations were observed in intramembranous
and endochondral bones, along with in teeth. Compared with
wild-type (WT)mice, Ltbp3-nullmutants presentedwith anoverall
reduction in craniofacial size and modifications of the shape of
various parts of the craniofacial skeleton. Modifications of viscer-
ocranium, neurocranium andmandiblewere prominent changes.
Some of the skeletal and growth anomalies observed in the
Ltbp3−/− mice were also present in our patients (short maxilla,
mandibular prognathism) but others (such as the increased
bone density) were not present, underscoring the fact that the
mouse phenotype is not always recapitulating the human
phenotype. We do know secreting ameloblasts express Ltbp3.
The enamel was clearly defective in the mouse mutant. It was
thinner, lessmineralized and exhibited an unusual wavy pattern
with alternating area of presence/absence. Both incisors andmo-
lars were affected. Ltbp3−/− ameloblasts as seen on histological
sections of continuously growing incisor enamel organ were, in
spotted area, able to synthesize an extruding NPE matrix con-
firming at the cellular level the impaired amelogenesis and the
wavy pattern appearance.
This knockout-mice is now to be inscribed in the list of animal
models presenting with enamel defects (38) and will likely serve
as an important model to study further brachyolmia with AI (39).
In conclusion, the study of four unrelated families with the
association of AI and brachyolmia has led to the identification
of LTBP3 as causal gene. Our study not only confirms the exist-
ence of this rare, autosomal recessive disorder but also highlights
the role of LTBP3 and TGF-beta signaling in amelogenesis, both in
humans and mice. It also adds another member to the growing
list of genes causing isolated and syndromic forms of brachyol-
mia. Study of additional families is warranted for better under-
standing of the phenotypic spectrum of this disorder given the
wide expression of the LTBP3 gene.
Materials and Methods
Patients
In Family 1, two sisters born from a consanguineous family of
Turkish origin were referred to the Reference Center for Rare Or-
odental Diseases at the StrasbourgUniversity Hospital because of
pain and enamel defects (Fig. 1). Besides short stature (140 cm
adult height, −4.2 SD), they also showed facial dysmorphism
with large forehead, thick eyebrows, almond shaped eyes,
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myopia and mild learning difficulties. Radiographs of the skel-
eton revealed brachyolmia (Fig. 1E and F) and there were no
signs of a generalized skeletal dysplasia. Bone age was consid-
ered as normal.
Their orodental findings were documented using the D[4]/
phenodent Diagnosing Dental Defects Database registry (www.
phenodent.org).
Enamel was almost absent (hypoplastic AI) in both primary
and permanent dentitions (Fig. 1A and B). The teeth were yellow,
small and spaced. Several teethwere surgically extracted because
of recurrent infections. On orthopantomogram, no enamel was
observed, pulp chamberswere large andmolarswere taurodontic
(Fig. 1C). Lateral cephalogram showed somewhat thickened cor-
tical plates of the frontal bone and an absence of pneumatization
of the frontal and sphenoid sinuses. Posterior clinoid apophyses
of the sphenoid were abnormally shaped. Class III mandibular
prognathism was due to maxillary underdevelopment (Fig. 1D).
Family 2 consisted of two sibs born to non-consanguineous,
unrelated Caucasian parents. The female proband (III.6) is the
sixth child. Birth weight was 2.760 g, birth length 46 cm and
head circumference was 33 cm at 39 weeks of gestation. She had
normal psychomotor development and no general health pro-
blems. Primary teethwere small and yellowishwith a poor square
morphology and rounded cusps without pronounced fissures.
The enamel was smooth and showed external crown resorption
beforemolars erupted. She suffered of repeated dental abscesses,
leading to the extraction of several teeth at ages 2½ and 5 years.
When seen at age 8, she had clearly hypoplasic AI, microdontia
and taurodontism. At age 13, she was 149 cm tall (−1.5 SD),
weighed 42 kg and had an occipital-frontal circumference of
51 cm. She had a triangular face with retraction of the midface.
She had short hands with stubby interphalangeal joints. Pro-
and supination movements were limited. Osteotendinous
reflexes in the lower limbs were jerky. Single nucleotide poly-
morphism (SNP)-array was normal (Illumina CytoSNP-12 v2)
and did not reveal homozygosity stretches. Radiographs showed
mild platyspondyly. Her brother (III.7) was the seventh sib of the
family. He was prematurely born at 28 weeks of gestation and re-
mained in the intensive neonatal care unit for 3 months, without
major cardiopulmonary or neurological complication. Inguinal
herniae were surgically corrected. He walked at age 14 months
and his first words were delayed to 2½ years. He required speech
therapy. When examined at age 5½ year-old, he was 101 cm tall
(−3 SD), weighed 16 kg and had a head circumference of
48.5 cm. His teeth were small and yellow lacking enamel. He
had a triangular face, converging squint, a narrow thorax with
prominent sternum and hypermobile small joints. The family
history was unremarkable. Parents had normal height (175 cm
for the father and 170 for the mother) and teeth. The six other
sibs were normal.
Family 3 has been described previously by Bertola et al. (4). The
proband is a 12-year-old boy from consanguineous and healthy
parents. The patient sat unsupported at 8 months of age, walked
at 12 months, said his first words at 2 years. Although themother
refers some difficulties in learning, he attends a regular school
(currently last year of high school). He presented with short stat-
ure (height at −3 SD for age) and enamel defects in the primary
and permanent dentition. A panoramic radiograph revealed
taurodontic pulp chambers of the permanent teeth. Skeletal sur-
vey showed mild flattening of the vertebral bodies with minimal
posterior scalloping and no evidence of a generalized epi- or me-
taphyseal dysplasia. Mother and father have normal height (145
and 162.5 cm, respectively) and dental status. This was con-
firmed by clinical and X-ray examinations.
Family 4 includes three affected sibs in a sibship of five chil-
dren born to first cousin parents of Pakistani origin. The three af-
fected children, two girls and one boy of, respectively, 16, 9 and
12 years of age, presented with short stature (height ranging
from −2 to −5 SD). They were disproportionate with short trunk
due to a generalized platyspondyly. Radiographs showed osteo-
penia and mild vertebral flattening with posterior scalloping
and superior and inferior indentations in the posterior third of
the lumbar vertebrae. The oldest girl underwent surgery for an
S-shaped scoliosis. The scoliosis in the two other childrenwas ra-
ther mild. Recurrent dental abscesses were noted and the dental
practitioner confirmed a diagnosis of AI with missing teeth.
None of the family members had intellectual disability. The
father’s height was 165.2 cm (3rd–10th centile), and the mother’s
height was 149.4 cm (>3rd centile). None of the unaffected mem-
ber of the family have skeletal nor dental anomalies.
Genetic analyses
This study was approved by the ethics committee of the Stras-
bourg University Hospital (ClinicalTrials.gov Identifier:
NCT01746121). Informed consent and DNA samples were ob-
tained from all participating individuals. Genomic DNAwas iso-
lated either from blood using the Flexigene DNA kit (Qiagen,
Courtaboeuf, France) or from saliva using the prepIT-L2P OG-
250 Oragene®DNA kit (DNA Genotek Inc., ON, Canada). Whole-
exome sequencing was performed by IntegraGen (Evry, France).
The coding parts of the genomewere captured using the SureSe-
lect Human All Exon Kits V5+UTR 70 Mb (Agilent, Massy, France)
and the resulting libraries were sequenced as paired-end 75 base
pair reads on a HiSeq 2000 (Illumina, San Diego, USA). Image ana-
lysis and base calling were performed using the Real Time Ana-
lysis (RTA) Pipeline version 1.9 with default parameters
(Illumina). The bioinformatic analysis of sequencing data was
based on the CASAVA1.8 pipeline (Illumina). CASAVA performs
alignment anddetects variants (SNPs and indels) based on the al-
lele calls and read depth. The variants were annotated and prior-
itized using an in-house pipeline VaRank (http://lbgi.fr/VaRank/,
(40) (41).
Sanger sequencing (GATC Biotech, Applied Biosystems ABI
3730xl™, Konstanz, Germany) was used to validate the muta-
tions and verify segregation using the primers shown in Supple-
mentary Material, Table S2.
Homozygositymapping via GeneChipHuman 250 K SNPAffy-
metrix was performed as previously described (42) in family 1 on
affected individuals IV.1, IV.2, on the unaffected individual IV.3
and both parents III.3 and III.4 (Supplementary Material, Fig. S1).
cDNA analysis
RNA was extracted from fibroblasts of patient IV.1 (gingival bi-
opsy) and one unrelated control by using a RiboPure™ Kit, fol-
lowed by a DNAse treatment with the TURBO DNA-free™ Kit
(Life Technologies, Carlsbad, CA). RNA integrity was assessed by
gel electrophoresis and RNA concentration was measured with
the Eppendorf Biophotometer Plus™with the Hellma® TrayCell™
(Eppendorf, Hamburg, Germany). Reverse transcription of 1 µg
total RNA to cDNAwas performed using the iScript™ cDNA Syn-
thesis Kit (BioRad, Hercules, CA). Reverse transcription polymer-
ase chain reaction was performed to determine the exon
content of the cDNA from the patient. Primers used for reverse
transcription polymerase chain reaction are shown in Supple-
mentary Material, Table S2.
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Scanning electron microscopy
The permanent left upper second premolar (25) of patient IV2,
family 1, as well as an identical control tooth, were available for
the comparative study of enamel AI/control ultrastructure. After
extraction, the teethwere rinsedwith tapwater and immersed in
a sodiumhypochlorite solution (1.2 chlorometric degree) for 24 h.
After a rinsing with distilled water the tooth was dehydrated in a
graded series of ethanol, transferred in a solution of propylene
oxide/epon resin (v/v) for 24 h, then embedded in Epon 812 (Euro-
medex, Souffelweyersheim, France). The tooth was sectioned
into two halves along its vertical axis using a water-cooled dia-
mond circular saw (Bronwill, NY, USA) and both surfaceswere po-
lishedwith diamond paste (Escil, Chassieu, France). One half was
then etchedwith a 20% (m/v) citric acid solution for 2 min, rinsed
with distilled water, dehydrated in a graded series of ethanol so-
lutions and finally left to dry at room temperature. The samples
were coated with a gold–palladium alloy using a HUMMER JR
sputtering device (Technics, CA, USA). Scanning electron micro-
scope assessments and microanalysis (Energy dispersive X-ray)
were performed with a XL SIRION 200 FEG SEM (FEI company,
Eindhoven, The Netherlands) operating with an electron acceler-
ating voltage of 5 kV.
In situ hybridization
Sample preparation
Mouse embryos/fetuses were collected at E12.5, E14.5, E16.5 and
E18.5, after natural mating between C57BL6 mice. All experi-
ments were carried out in accordance with the European Com-
munity Council Directive of 24 November 1986 (86/609/EEC).
The projectwas approved by the ICS/IGBMCanimal experimenta-
tion ethics committee (2012-097). For E14.5 and older samples,
the whole body was embedded in OCT 4583 medium (Tissue-
TEK, Sakura) and frozen on the surface of dry ice. E12.5 embryos
were fixed overnight in 4% paraformaldehyde (pH 7.5, w/v) in
phosphate buffered saline (PBS), cryoprotected byovernight incu-
bation in 20% sucrose (w/v) in PBS and cryoembedded as de-
scribed above. Cryosections (Leica CM3050S cryostat) at 10 µm
were collected on Superfrost plus slides and stored at −80°C
until hybridization. E12.5 and E14.5 samples were sectioned in a
frontal plane, whereas other stages were sectioned sagitally.
Probe synthesis
The Ltbp3 probe was synthesized from PCR-generated DNA tem-
plates kindly provided by the EURExpress consortium (http://
www.eurexpress.org). The template sequence is given in Supple-
mentary Material, Fig. S3. DIG-labeled antisense riboprobe was
transcribed in vitro by incubation for 2 h at 37°C using 1 µg of
the PCR product, 20 U SP6 RNA polymerase, 5× transcription buf-
fer (Promega), 10× DIG RNA labelingMix (Roche), 0.5 M 1,4-Dithio-
threitol, 20 U RNAse inhibitor (Roche) in a 20-µl volume. The
reaction was stopped with 2 µl EDTA (0.2 , pH 8), and RNA was
precipitated with 1 µl yeast tRNA (10 mg/ml), 2.5 µl LiCl (4 M)
and 75 µl absolute ethanol, followed by an incubation for
30 min at −80°C and centrifugation at 12 000 rpm (30 min at 4°
C). The pellet was washed with 0.5 ml ethanol (70%) and re-cen-
trifuged. The supernatant was discarded and the pellet was al-
lowed to dry. The probe was then diluted in 20 µl sterile
H2O. The quality of the probe was verified by electrophoresis in
a 1% agarose gel. If no smearwas observed and the sizewas as ex-
pected, the probe was considered to be ready for use. The quan-
tity of RNA was evaluated by Nanodrop (ND-1000
Spectrophotometer, Labtech) and adjusted to 150 ng/µl in hybrid-
ization buffer, then stored at −20°C until use.
In situ hybridization
In situ hybridization was performed as previously described (43).
MicroCT imaging
Fixed in ethanol heads of 7 (5 × 3.5 months-old and 2 × 5.5
months-old) mutant Ltbp3−/− mice and 7 WT littermates were
analyzed through X-ray micro-CT using Quantum FX® microCT
Pre-clinical In Vivo Imaging System (Caliper Life Sciences, Inc.,
Hopkinton, MA, USA), which operates at an energy of 80 kV and
current intensity of 160 µA, with high-resolution detection at
10–295 μm pixel size. 3D data reconstructions were performed
using Analyze software (v 11.0; Biomedical Imaging Resource,
Mayo Clinic, Rochester, MN). Animals necropsy material was
kindly provided by B. Dabovic and D.B. Rifkin, Department of
Cell Biology, NYU Langone Medical Center, New York, NY.
Histological analysis
Fixed in 10% formalin and then transferred in 70% ethanol, heads
of 3.5 months-old WT and Ltbp3−/− mice were washed in water
and then demineralized in EDTA 10% in H2O at 37°C for 10 days
(the demineralizing solution was changed every day for the first
3 days and then every other day). After thorough water washes,
the heads were dehydrated in graded ethanol, cleared in histosol
and embedded in paraffin at 60°C. 10 µm transversal sections
were stainedwith hematoxylin/eosin. A detailed histology proto-
col can be found at http://www.empress.har.mrc.ac.uk.
Supplementary Material
Supplementary Material is available at HMG online.
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